Debanjan Ray has more than 10 years of experience in the biotechnology industry, including strategic consulting, venture capital and business development.
Prior to joining CytomX in August of 2011, Mr. Ray was the vice president of business development at Itero Biopharmaceuticals, where he helped drive several collaborations including the company's partnership on its lead product with Watson Pharmaceuticals.
Prior to Itero, Mr. Ray was an associate director of business development at Portola Pharmaceuticals.
Previously, Mr. Ray was an associate in the life sciences venture practice at J.P. Morgan Partners and a business analyst in the healthcare practice at McKinsey & Company.
Mr. Ray holds a dual B.S. in chemical engineering and biology from the Massachusetts Institute of Technology and an M.B.A. from The Wharton School, University of Pennsylvania.